The vet pharmacy start-up recently acquired NexGen Animal Health to meet the rising demand.
US-based veterinary pharmacy Mixlab, backed by private equity firm Vanterra Ventures, has acquired Texas-headquartered NexGen Animal Health to expand its business to new animals.
Through this acquisition, the company is expected to expand its care operations to include large species like equines, exotic animals, wildlife and zoo animals.
“This acquisition marks a key milestone for Mixlab as we expand our offering with sterile and non-sterile preparations for the equine, wildlife and zoo markets,” says the company’s CEO Fred Dijols.
The acquisition will also enable growth in capacity, formulary and customer care teams by adding a fourth location in Texas. The firm currently has sites in New York, California and Florida.
Mixlab closed a $10 million (€9.1M) funding round last August as part of its Series A funding extension.
The latest articles
These pet players are expanding their reach through retail partnerships
Pet brands are increasingly partnering with distribution companies to increase their product reach and tap into new markets.
Retail, Online & DTC
8 Oct 2024
Indian insect player secures permit to export to Europe
Arthro Biotech outlines ambitious plans to increase production to 100,000 tons annually by 2030.
Ingredients
8 Oct 2024
AgroBiothers makes second acquisition in European pet care space
The addition of Denmark’s leading pet care business, KW, marks a strategic move to strengthen the French pet care company’s position in Northern Europe.
Pet Care
7 Oct 2024
GET THE NEWSLETTER
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.